Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Emily Y. Chu, MD, PhD

Emily Y. Chu, MD, PhD Physician

Assistant Professor of Dermatology at the Hospital of the University of Pennsylvania
Assistant Professor of Pathology and Laboratory Medicine

Languages spoken:

  • Mandarin

Dr. Chu is a Penn Medicine employed physician.

Clinical Specialties

Specialty:

  • Dermatology

Programs & Centers:

Board Certification:

  • Dermatology - Dermatopathology, 2012
  • Dermatology, 2010

Clinical Expertise:

  • Adverse Drug Reaction
  • Basal Cell Carcinoma
  • Dermatopathology
  • Dysplastic Nevi (Atypical Moles)
  • Genetic Skin Disorders
  • Radiation Dermatitis
  • Skin Cancer
  • Squamous Cell Carcinoma
  • Tuberous Sclerosis

Description of Clinical Expertise

Dermatopathology
Melanoma
Inherited skin tumor syndromes
Cutaneous reactions to targeted and immunotherapies

Practice Locations and Appointments

  • Penn Dermatology

    Perelman Center for Advanced Medicine South Pavilion, 1st Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-PENN (7366)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: University of Pennsylvania School of Medicine
Residency: Memorial Sloan-Kettering Cancer Center
Residency: Hospital of the University of Pennsylvania
Fellowship: Hospital of the University of Pennsylvania

Memberships

American Academy of Dermatology, National American Society for Dermatopathology, National Dermatology Foundation, National International Society for Dermatopathology, International Medical Dermatology Society, National Pennsylvania Academy of Dermatology, Local Philadelphia Dermatological Society, Local Society for Melanoma Research, International Society of Investigative Dermatology, National Society of Pediatric Dermatology, National Women's Dermatologic Society, National

Hospital Affiliation

Dr. Chu is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

Molecular markers for melanoma

Selected Publications:

Marek Andrew J, Ming Michael E, Bartlett Edmund K, Karakousis Giorgos C, Chu Emily Y: Acral Lentiginous Histologic Subtype and Sentinel Lymph Node Positivity in Thin Melanoma. JAMA dermatology 152 (7): 836-7,2016.

Mochel Mark C, Ming Michael E, Imadojemu Sotonye, Gangadhar Tara C, Schuchter Lynn M, Elenitsas Rosalie, Payne Aimee S, Chu Emily Y: Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma. Journal of cutaneous pathology : 2016.

Lott Jason P, Elmore Joann G, Zhao Ge A, Knezevich Stevan R, Frederick Paul D, Reisch Lisa M, Chu Emily Y, Cook Martin G, Duncan Lyn M, Elenitsas Rosalie, Gerami Pedram, Landman Gilles, Lowe Lori, Messina Jane L, Mihm Martin C, van den Oord Joost J, Rabkin Michael S, Schmidt Birgitta, Shea Christopher R, Yun Sook Jung, Xu George X, Piepkorn Michael W, Elder David E, Barnhill Raymond L: Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group. Journal of the American Academy of Dermatology 75 (2): 356-63,2016.

Sargen M R, Merrill S L, Chu E Y, Nathanson K L: CDKN2A mutations with p14 loss predisposing to multiple nerve sheath tumours, melanoma, dysplastic nevi, and internal malignancies: A case series and review of the literature. The British journal of dermatology : 2016.

Braunstein, I., Gangadhar, T., Elenitsas, R. & Chu, E.Y.: Vemurafenib-induced interface dermatitis manifesting as radiation-recall and a keratosis pilaris-like eruption Journal of Cutaneous Pathology 41 (6): 539-43,2014.

Chu, E.Y., Wanat, K.A., Miller, C.J., Amaravadi, R.K., Fecher, L.A., Brose, M.S., McGettigan, S., Giles, L.R., Schuchter, L.M., Seykora, J.T., Rosenbach, M.: Diverse cutaneous side effects associated with BRAF inhibitor therapy: A clinicopathologic study J Am Acad Dermatol 67 (6): 1265-1272,2012.

Chu, E. Y., Freeman, A. F., Jing, H., Cowen, E. W., Davis, J., Su, H. C., Holland, S. M., Turner, M. L.: Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol 148 (1): 79-84,2012.

Lang, D.,Lu, M.M., Huang, L., Engleka, K.A., Zhang, M., Chu, E.Y., Lipner, S., Skoultchi, A., Millar, S.E., Epstein, J.A.: Pax3 functions at a nodal point in melanocyte stem cell differentiation Nature 433 (7028): 884-7,2005.

Chu, E.Y., Hens, J., Andl, T., Kairo, A., Yamaguchi, T.P., Brisken, C., Glick, A., Wysolmerski, J.J., Millar, S.E.: Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis Development 131 (19): 4819-29,2004.

Li, F., Ambrosini, G., Chu, E.Y., Plescia, J., Tognin, S., Marchisio, P.C., Altieri, D.C.: Control of apoptosis and mitotic spindle checkpoint by survivin Nature 396 (6711): 580-4,1998.

Academic Contact Info

2 Maloney Building
3600 Spruce Street

Philadelphia, PA 19104
Phone: (215) 662-6926
Fax: (215) 662-7884
Patient appointments: 800-789-PENN (7366)